Icon

PLEGINE (NDA012248)- (35MG)

PHENDIMETRAZINE TARTRATE WYETH AYERST
35MG
No No
Expired Expired
None None
None No
PLEGINE is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of greater than or equal to 30 kg/m2 or greater than or equal to 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia) who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone.
5 0 3
Total Other Developers None
Drugs with Suitability No
35MG ** ** - - 3
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ***** ************, ***. *********** *** ****** ******, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** *** **** ***-****, ***. *********** *** ***** **., *******, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.